Paper published in a journal (Scientific congresses and symposiums)
Cost-effectiveness of Denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women
Hiligsmann, Mickaël; Reginster, Jean-Yves
2011In Osteoporosis International, 22 (Suppl.1), p. 112-113
Peer Reviewed verified by ORBi
 

Files


Full Text
OC36.pdf
Publisher postprint (62.17 kB)
Request a copy
Annexes
OC36.pdf
Publisher postprint (377.02 kB)
Communication orale
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Rheumatology
Special economic topics (health, labor, transportation...)
Public health, health care sciences & services
Author, co-author :
Hiligsmann, Mickaël ;  Université de Liège - ULiège > Département des sciences de la santé publique & HEC-Ecole de Gestion
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Cost-effectiveness of Denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women
Publication date :
March 2011
Event name :
European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF
Event organizer :
International Osteoporosis Foundation and National Osteoporosis Foundation 2011
Event place :
Valencia, Spain
Event date :
du 23 mars 2011 au 26 mars 2011
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
22
Issue :
Suppl.1
Pages :
S112-113
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 07 April 2011

Statistics


Number of views
128 (11 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi